Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria

American Journal of Hematology - United States
doi 10.1002/ajh.24280
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

The Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria and Treatment With Eculizumab

Therapeutics and Clinical Risk Management
2009English

Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient With Paroxysmal Nocturnal Hemoglobinuria

Case Reports in Hematology
2015English

Eculizumab in Paroxysmal Nocturnal Hemoglobinuria With Budd-Chiari Syndrome Progressing Despite Anticoagulation

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2012English

Orphan Designation: Eculizumab, Treatment of Paroxysmal Nocturnal Haemoglobinuria

Case Medical Research
2019English

Effectiveness of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With or Without Aplastic Anemia in the International PNH Registry

American Journal of Hematology
Hematology
2018English

Effects of Immunosuppressive Therapy in a Patient With Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria (AA-PNH) Syndrome During Ongoing Eculizumab Treatment

Internal Medicine
Internal MedicineMedicine
2014English

Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed

Indian Journal of Hematology and Blood Transfusion
Hematology
2016English

Acute Myeloblastic Leukemia in Paroxysmal Nocturnal Hemoglobinuria. Evidence of Evolution From the Abnormal Paroxysmal Nocturnal Hemoglobinuria Clone.

Journal of Clinical Investigation
Medicine
1987English

Paroxysmal Nocturnal Hemoglobinuria: When Delay in Diagnosis and Long Therapy Occurs

Hematology Reports
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy